Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:04:00.082Z.
Calculation as of: 2026-10-06T20:04:00.082Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d00a9c235f8f3f2200d332a4911885706ef223ec632fccfa45bb3326c1a5dd06
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$97.94M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$99.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$95.14M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$101.36M
Operating Cash Flow Yield
5.31%
TTM Avg
2.90%
3Y Avg
5.27%
5Y Avg
4.78%
Market Cap
$93.96M
Operating Cash Flow Yield
10349.70%
TTM Avg
3068.81%
3Y Avg
3068.81%
5Y Avg
3068.81%
Market Cap
$102.75M
Operating Cash Flow Yield
N/A
TTM Avg
6.71%
3Y Avg
6.71%
5Y Avg
6.71%
Market Cap
$103.14M
Operating Cash Flow Yield
N/A
TTM Avg
12.54%
3Y Avg
12.54%
5Y Avg
12.54%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PolyPid Ltd. (PYPD) | $97.90M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A | N/A | N/A | N/A |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $95.14M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $101.36M | 5.31% | 2.90% | 5.27% | 4.78% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | 10349.70% | 3068.81% | 3068.81% | 3068.81% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.75M | N/A | 6.71% | 6.71% | 6.71% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | N/A | 12.54% | 12.54% | 12.54% |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 39.74% | 38.13% | 19.19% | 12.42% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
